Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis

This publication has 13 references indexed in Scilit:

• Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsia
  BJOG: An International Journal of Obstetrics and Gynaecology, 1994
• Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia
  Blood, 1989
• 76 Determination of PAI-1 activity in pregnancy plasma requires the use of single-chain tPA
  Fibrinolysis, 1988
• Fibrinolysis during normal human pregnancy: complex inter‐relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time
  British Journal of Haematology, 1988
• Changes in the plasma levels of vitamin K‐dependent proteins C and S and of C4b‐binding protein during pregnancy and oral contraception
  British Journal of Haematology, 1988
• Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives
  Thrombosis Research, 1988
• Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors
  Blood, 1987
• Plasminogen Activator Inhibitor-1 Is the Primary Inhibitor of Tissue-Type Plasminogen Activator in Pregnancy Plasma
  Thrombosis and Haemostasis, 1987
• Functional and immunologic protein S levels are decreased during pregnancy
  Blood, 1986
• The coagulation factor VII in pregnancy
  British Journal of Haematology, 1984